title: Intramedullary spinal cord hemorrhage after treatment with bevacizumab in a long-term survivor with metastatic non-small-cell lung cancer.
authors.affiliation: *Division of Hematology/Oncology; and †Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX.
authors.forename: Kristin N
authors.initials: KN
authors.lastname: Arreola
authors.forename: James
authors.initials: J
authors.lastname: Ying
authors.forename: Randall
authors.initials: R
authors.lastname: Hughes
authors.forename: David E
authors.initials: DE
authors.lastname: Gerber
authors.forename: D W Nathan
authors.initials: DW
authors.lastname: Kim
mesh_terms: D020533:Angiogenesis Inhibitors / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use; D000068258:Bevacizumab; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000556:secondary; D006470:Hemorrhage / Q000209:etiology*; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000473:pathology; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D013120:Spinal Cord Neoplasms / Q000150:complications* / Q000532:radiotherapy* / Q000556:secondary
chemical_list: D020533:Angiogenesis Inhibitors; D061067:Antibodies, Monoclonal, Humanized; D000068258:Bevacizumab